
TY  - JOUR
TI  - OSTEOPOROSIS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_20.x
DO  - doi:10.1111/j.1479-8077.2006.00199_20.x
SP  - A125
EP  - A142
PY  - 2006
ER  - 

TY  - JOUR
TI  - SPONDYLOARTHROPATHIES INCLUDING PSORIATIC ARTHRITIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_28.x
DO  - doi:10.1111/j.1479-8077.2006.00199_28.x
SP  - A234
EP  - A247
PY  - 2006
ER  - 

TY  - JOUR
TI  - BACK PAIN
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_3.x
DO  - doi:10.1111/j.1479-8077.2006.00199_3.x
SP  - A26
EP  - A31
PY  - 2006
ER  - 

TY  - JOUR
TI  - BONE DISEASES OTHER THAN OSTEOPOROSIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_4.x
DO  - doi:10.1111/j.1479-8077.2006.00199_4.x
SP  - A31
EP  - A33
PY  - 2006
ER  - 

TY  - JOUR
TI  - SYSTEMIC LUPUS ERYTHEMATOSUS – AETIOLOGY AND PATHOGENESIS/ANIMAL MODELS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_29.x
DO  - doi:10.1111/j.1479-8077.2006.00199_29.x
SP  - A247
EP  - A253
PY  - 2006
ER  - 

TY  - JOUR
TI  - CARTILAGE IN BONE BIOLOGY AND PATHOPHYSIOLOGY
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_5.x
DO  - doi:10.1111/j.1479-8077.2006.00199_5.x
SP  - A33
EP  - A39
PY  - 2006
ER  - 

TY  - JOUR
TI  - METABOLIC AND CRYSTAL ARTHROPATHIES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_15.x
DO  - doi:10.1111/j.1479-8077.2006.00199_15.x
SP  - A83
EP  - A90
PY  - 2006
ER  - 

TY  - JOUR
TI  - OSTEOARTHRITIS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_19.x
DO  - doi:10.1111/j.1479-8077.2006.00199_19.x
SP  - A108
EP  - A125
PY  - 2006
ER  - 

TY  - JOUR
TI  - ANTI-PHOSPHOLIPID SYNDROME
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_2.x
DO  - doi:10.1111/j.1479-8077.2006.00199_2.x
SP  - A25
EP  - A26
PY  - 2006
ER  - 

TY  - JOUR
TI  - PAEDIATRIC RHEUMATOLOGY
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_22.x
DO  - doi:10.1111/j.1479-8077.2006.00199_22.x
SP  - A159
EP  - A167
PY  - 2006
ER  - 

TY  - JOUR
TI  - RHEUMATOID ARTHRITIS – TREATMENT
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_24.x
DO  - doi:10.1111/j.1479-8077.2006.00199_24.x
SP  - A188
EP  - A210
PY  - 2006
ER  - 

TY  - JOUR
TI  - SJOGREN'S SYNDROME
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_27.x
DO  - doi:10.1111/j.1479-8077.2006.00199_27.x
SP  - A230
EP  - A234
PY  - 2006
ER  - 

TY  - JOUR
AU  - Diwan, A. H.
AU  - Kim, K.
AU  - Zhang, P.
AU  - Prieto, V. G.
TI  - Activated Protein Kinases and Overall Survival in Patients with Metastatic Melanoma.
JO  - Journal of Cutaneous Pathology
VL  - 32
IS  - 1
SN  - 0303-6987
UR  - https://doi.org/10.1111/j.0303-6987.2005.320bj.x
DO  - doi:10.1111/j.0303-6987.2005.320bj.x
SP  - 85
EP  - 85
PY  - 2005
AB  - Protein tyrosine kinases (PTK) are proteins that may play importants roles in survival, proliferation and progression to metastasis in several tumors, including melanoma. There is little information on the expression pattern of the phosphorylated (i.e. activated) forms of such kinases in melanoma and their impact on overall survival (OS). We sought to determine the expression, by immunohistochemistry, of phosphorylated MAP kinase (pMAPK), Akt (pAkt) and C-kit (pCkit) in primary and metastatic melanoma, and their correlation with OS. Fifteen patients with Stage III and Stage IV (metastatic melanoma) disease were randomly selected from the UT MD Anderson database. Expression was rated by two investigators on intensity (negative, weak, moderate, and strong) and proportion of reactive tumor cells (0?=?<5%, 1?=?5?25%, 2?=?>25?75%, 3?=?>75%). Eleven of the 15 tumors (primary and/or metatasis) exhibited pMAPK expression (73%). Corresponding percentages were 100% for pAKT and <50%(7/15) for pCkit. OS ranged from less than one year to 9 years. However, there was no correlation between OS and expression of any of these markers.
ER  - 

TY  - JOUR
TI  - FREE COMMUNICATIONS  POSTER COMMUNICATIONS
JO  - Nephrology
VL  - 10
IS  - s1
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.2005.00419.x
DO  - doi:10.1111/j.1440-1797.2005.00419.x
SP  - A1
EP  - A116
PY  - 2005
ER  - 

TY  - JOUR
TI  - CELL RECEPTOR-LIGAND INTERACTION, SIGNALING AND ACTIVATION
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_6.x
DO  - doi:10.1111/j.1479-8077.2006.00199_6.x
SP  - A39
EP  - A39
PY  - 2006
ER  - 

TY  - JOUR
TI  - CYTOKINES AND INFLAMMATORY MEDIATORS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_7.x
DO  - doi:10.1111/j.1479-8077.2006.00199_7.x
SP  - A39
EP  - A45
PY  - 2006
ER  - 

TY  - JOUR
AU  - Kim, Y.O.
AU  - Song, W.J.
AU  - Park, J.A.
AU  - Yoon, S.A.
AU  - Kim, Y.S.
AU  - Chang, Y.S.
AU  - Bang, B.K.
TI  - The effect of dialysis needle size on hemodialysis adequacy
JO  - Hemodialysis International
VL  - 9
IS  - 1
SN  - 1492-7535
UR  - https://doi.org/10.1111/j.1492-7535.2005.1121o.x
DO  - doi:10.1111/j.1492-7535.2005.1121o.x
SP  - 76
EP  - 76
PY  - 2005
AB  - Objective:? Dialysis adequacy indexed by Kt/V in hemodialysis (HD) patients is recommended as a single pool Kt/V at least 1.2 per session thrice weekly. But many patients cannot achieve this adequacy target. Although dialysis time is the most important factor influencing Kt/V, it is difficult to prolong dialysis time in practice because of its economic impact and poor patient compliance. This study was performed to investigate the effect of increasing dialysis needle size on dialysis adequacy in HD patients. Methods:?This study enrolled 73 patients receiving HD thrice weekly for more than 3 months with arteriovenous fistula (AVF) or graft in a single center. Dialysis blood flow rate was 200?ml/min in 12 patients, 250?ml/min in 32 patients, and 300?ml/min in 29 patients. Surface area of dialyzer was 1.2?m2 in 56 patients and 1.6?m2 in 17 patients. We first performed HD using a 16-gauge needle. Then we increased needle size up to 15-gauge without change of any other dialysis conditions such as blood and dialysate flow rates, dialysis time, or distance between needle insertion sites. We compared compression time after removing the needles, venous dialysis pressure (VDP), Kt/V, and urea reduction ratio (URR) between these two methods. Results:?The mean age was 54?±?13 years and the number of patients with diabetes mellitus was 27 (37%). Fifty-eight patients (79.5%) have native AVF. Mean Kt/V at HD method using a 15-gauge needle was higher than at HD method using a 16-gauge needle (1.30?±?0.18 vs. 1.23?± 0.18, p?<?0.001). URR at HD method using a 15-gauge needle was also higher than at HD method using a 16-gauge needle. In contrast, VDP at HD method using a 15-gauge needle was lower than at HD method using a 16-gauge needle (88?±?22?mmHg vs. 118?±?28?mmHg, p?<?0.001). There was no difference in compression time between the two methods. Conclusion:?This study suggests that increasing dialysis needle size is a safe and effective method in improving dialysis adequacy without increasing blood flow rate or dialysis time.
ER  - 

TY  - JOUR
AU  - Krause, Elizabeth
AU  - Bhan, Mona
TI  - Association for Political and Legal Anthropology
JO  - Anthropology News
VL  - 49
IS  - 3
SN  - 1541-6151
UR  - https://doi.org/10.1525/an.2008.49.3.44.2
DO  - doi:10.1525/an.2008.49.3.44.2
SP  - 44
EP  - 45
KW  - APLA
KW  - Section News
KW  - Elizabeth Krause
KW  - Mona Bhan
KW  - Carie Little Hersh
KW  - Jason Cross
KW  - Sally Engle Merry
KW  - Andrea Ballestero
KW  - Amy Levine
KW  - John Bowen
KW  - Bret Gustafson
KW  - Tony Crook
KW  - Bill Maurer
KW  - Kim Fortun
KW  - David Hess
KW  - Peter Redfield
KW  - Michael Lambek.
KW  - Student Mentoring Workshop
PY  - 2008
AB  - ?Graduate Student Participation in APLA?Carie Little Hersh ?
ER  - 

TY  - JOUR
AU  - KANG, HYEWON
AU  - LEE, HAEBEOM
AU  - KWAK, HYOSUNG
AU  - KIM, NAMSOO
AU  - LEE, KICHANG
TI  - IMAGING DIAGNOSIS—CONGENITAL STRUCTURAL HYOID BONE ABNORMALITIES IN A DOG
JO  - Veterinary Radiology & Ultrasound
VL  - 49
IS  - 4
SN  - 1058-8183
UR  - https://doi.org/10.1111/j.1740-8261.2008.00379.x
DO  - doi:10.1111/j.1740-8261.2008.00379.x
SP  - 357
EP  - 359
PY  - 2008
ER  - 

TY  - JOUR
AU  - Weiss, Nicole H.
AU  - Darosh, Angela G.
AU  - Contractor, Ateka A.
AU  - Schick, Melissa M.
AU  - Dixon-Gordon, Katherine L.
TI  - Confirmatory validation of the factor structure and psychometric properties of the Difficulties in Emotion Regulation Scale-Positive
JO  - Journal of Clinical Psychology
JA  - J Clin Psychol
VL  - 75
IS  - 7
SN  - 0021-9762
UR  - https://doi.org/10.1002/jclp.22768
DO  - doi:10.1002/jclp.22768
SP  - 1267
EP  - 1287
KW  - confirmatory factor analysis
KW  - emotion dysregulation
KW  - measurement
KW  - positive emotions
KW  - psychometric validation
PY  - 2019
AB  - Abstract Objectives Emotion dysregulation is a transdiagnostic factor central to the etiology and treatment of various clinical difficulties. Yet, research in this area has focused almost exclusively on emotion dysregulation stemming from negative emotions. The current study confirmed the factor structure of the Difficulties in Emotion Regulation Scale-Positive (DERS-P) and further examined its reliability and validity. Method Participants in Study 1 were 229 college students (M age?=?19.37 years; 66.8% female; 67.2% White). Participants in Study 2 were 353 trauma-exposed community individuals ( M age?=?35.77 years; 57.8% female; 71.2% White). Results Findings supported the three-factor structure of the DERS-P. Mean levels of the DERS-P scales demonstrated convergent and discriminant validity and differentiated individuals with (vs. without) probable posttraumatic stress disorder, depression, alcohol use, and drug use disorders. Conclusions Findings provide additional support for the factor structure, reliability, and validity of the DERS-P, thereby adding to its clinical utility.
ER  - 
